Healthy Skepticism Library
Items published in 2004
There are 870 items in the Healthy Skepticism Library that were published in 2004.
Page 7 of 9 pages ‹ First < 5 6 7 8 9 >
HSL110
Willcocks P.
Health care consumers need a voice
Vancouver Sun 2004 Feb 7
HSL187
Gibson L.
Spanish drug editor wins case brought by Merck, Sharp Dohme.
BMJ 2004 Feb 7; 328:(7435):307
http://bmj.bmjjournals.com/cgi/content/full/328/7435/307-b
HSL188
Moynihan R.
FDA advisory panel calls for suicide warnings over new antidepressants.
BMJ 2004 Feb 7; 328:(7435):303
http://bmj.bmjjournals.com/cgi/content/full/328/7435/303-a
HSL189
Moynihan R.
Drug company targets US state health officials.
BMJ 2004 Feb 7; 328:(7435):306
http://bmj.bmjjournals.com/cgi/content/full/328/7435/306
HSL19754
Croft P
Constructing RSI: Belief and Desire
BMJ 2004 Feb 7; 328:(354):
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC338153/
HSL4474
Ong A, Mansfield PR.
Controversies: Should free drug samples be banned?
Australian Doctor Weekly 2004 Feb 6
HSL190
Mello MM, Studdert DM, Brennan TA.
The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.
N Engl J Med 2004 Feb 5; 350:(6):608-13
http://content.nejm.org/cgi/content/full/350/6/608
HSL17973
Elliot S
Proposed Changes to Ad Rules
The New York Times 2004 Feb 5
HSL106
Antidepressants May Cause Suicides
The New York Times 2004 Feb 4
HSL107
Landrigan K .
State may limit gifts from drug companies
Nashua Telegraph 2004 Feb 4
HSL108
Wahlberg D.
Advertisers probe brains, raise fears
The Atlanta Journal-Constitution 2004 Feb 4
HSL102
Vedantam , S .
FDA Links Antidepressants, Youth Suicide Risk
Washington Post 2004 Feb 3
http://www.washingtonpost.com/ac2/wp-dyn?pagename=article&contentId=A7008-2004Feb2¬Found=true
HSL103
Roner L .
A matter of trust
Eye For Pharma 2004 Feb 3
http://social.eyeforpharma.com/story/matter-trust
HSL104
Boseley S.
Company 'held back' data on drug for children: Antidepressant had no effect, leak reveals
The Guardian 2004 Feb 3
http://www.guardian.co.uk/science/2004/feb/03/sciencenews.highereducation
HSL105
Lawmaker Seeks Data on Antidepressants for Kids
Reuters 2004 Feb 3
HSL191
Morgan S.
Sources of variation in provincial drug spending.
CMAJ 2004 Feb 3; 170:(3):329-30
http://www.cmaj.ca/cgi/content/full/170/3/329
HSL19045
Schwartz LM, Woloshin S.
The media matter: a call for straightforward medical reporting.
Ann Intern Med 2004 Feb 3; 140:(3):226-8
http://www.ncbi.nlm.nih.gov/pubmed/14757622
HSL101
Clarke , T .
U.S. Probe Into Antidepressant Drug Makers Widens
Reuters 2004 Feb 2
HSL9780
Nelson MR.
Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners.
Med J Aust 2004 Feb 2; 180:(3):140
http://www.mja.com.au/public/issues/180_03_020204/letters_020204_fm-3.html
HSL9781
Gijsbers AJ, Whelan G.
E-drug deals: part of the Wild West world of e-commerce.
Med J Aust 2004 Feb 2; 180:(3):103-4
http://www.mja.com.au/public/issues/180_03_020204/gij10849_fm-1.html
HSL14668
Barlett DL, Steele JB, Karmatz L, Kiviat B, Levinstein J.
Why We Pay So Much for Drugs
Time 2004 Feb 2
http://www.time.com/time/magazine/article/0,9171,993223-1,00.html
HSL98
Seaman B.
Is This Any Way To Have a Baby
Oprah magazine 2004 Feb 1
HSL99
Petersen , M .
Making Drugs, Shaping the Rules
The New York Times 2004 Feb 1
http://www.nytimes.com/2004/02/01/business/making-drugs-shaping-the-rules.html
HSL100
Kendall J.
Talking back to Prozac
The Boston Globe 2004 Feb 1
http://www.boston.com/news/globe/ideas/articles/2004/02/01/talking_back_to_prozac/
HSL2394
Sleight P.
Where are clinical trials going? Society and clinical trials
Journal of Internal Medicine 2004 Feb 01; 255:151
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1365-2796.2003.01294.x
HSL2395
Lurk JT, DeJong DJ, Woods TM, Knell ME, Carroll CA.
Effects of changes in patient cost sharing and drug sample policies on prescription drug costs and utilization in a safety-net-provider setting.
Am J Health Syst Pharm 2004 Feb 1; 61:(3):267-72
http://www.ajhp.org/cgi/reprint/61/3/267
HSL185
Metzl JM, Angel J.
Assessing the impact of SSRI antidepressants on popular notions of women's depressive illness.
Soc Sci Med 2004 Feb; 58:(3):577-84
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-497YSNG-
HSL197
Faint Warning Archives
CBC News 2004 Feb
HSL514
Schafer A.
Biomedical conflicts of interest: a defence of the sequestration thesis-learning from the cases of Nancy Olivieri and David Healy.
J Med Ethics 2004 Feb; 30:(1):8-24
http://jme.bmjjournals.com/cgi/content/full/30/1/8
HSL1171
Drug costs: research and development costs: the great illusion
Prescrire Int 2004 Feb; 13:(69):32-6
HSL1786
Berman A.
Reducing medication errors through naming, labeling, and packaging.
J Med Syst 2004 Feb; 28:(1):9-29
HSL1788
Baylis F.
The Olivieri debacle: where were the heroes of bioethics?
J Med Ethics 2004 Feb; 30:(1):44-9
http://jme.bmjjournals.com/cgi/content/full/30/1/44
HSL2392
Ferris LE, Singer PA, Naylor CD.
Better governance in academic health sciences centres: moving beyond the Olivieri/Apotex Affair in Toronto.
J Med Ethics 2004 Feb; 30:(1):25-9
http://jme.bmjjournals.com/cgi/content/full/30/1/25
HSL2393
Holmes DR Jr, Firth BG, James A, Winslow R, Hodgson PK, Gamble GL, Popp RL, Harrington RA.
Conflict of interest
Am Heart J 2004 Feb; 147:(2):228-37
HSL4631
Moss F, Thomson R.
A new structure for quality improvement reports.
Qual Saf Health Care 2004 Feb; 13:(1):6-7
http://qhc.bmjjournals.com/cgi/content/full/13/1/6?maxtoshow=&HITS=10&hits=1
HSL9686
Petersen E.
Malaria chemoprophylaxis: when should we use it and what are the options?
Expert Rev Anti Infect Ther 2004 Feb; 2:(1):119-32
HSL9784
Fung CH, Woo HE, Asch SM.
Controversies and legal issues of prescribing and dispensing medications using the Internet.
Mayo Clin Proc 2004 Feb; 79:(2):188-94
HSL97
Ives N .
Study from an F.D.A. critic argues that the agency is slow to police misleading pharmaceutical ads.
The New York Times 2004 Jan 30
http://www.nytimes.com/2004/01/30/business/media-business-advertising-study-fda-critic-argues-that-agency-slow-police.html?scp=99&sq=&st=nyt&pagewanted=print?pagewanted=all
HSL93
Vedantam , S .
Antidepressant Makers Withhold Data on Children
The Washington Post 2004 Jan 29
HSL94
Cassels , A .
Pressure to use newer, pricier drugs can give taxpayers heartburn
The Vancouver Sun 2004 Jan 29
HSL95
Siig , M .
Life After Lipitor: Is Pfizer product a quick fix or dangerous drug? Residents experience adverse reactions
Tahoe World 2004 Jan 29
HSL96
Vatican condemns Aids drug firms
BBC News 2004 Jan 29
http://news.bbc.co.uk/2/hi/europe/3442217.stm
HSL4475
Richards D.
Guess who’s coming to dinner
Australian Doctor Weekly 2004 Jan 29
HSL92
Swartz S.
FDA Big Factor Behind High US Drug Costs
Reuters 2004 Jan 28
http://www.biotechblog.com/2004/01/30/107549363617383245/
HSL91
Japsen B.
Ex-TAP sales manager found guilty: 1st to go to trial in Lupron probe
Chicago Tribune 2004 Jan 27
http://articles.chicagotribune.com/2004-01-27/business/0401270256_1_astrazeneca-plc-lupron-lahey-clinic
HSL90
Why Are Drugs So Expensive?
The American Progress Report 2004 Jan 26
HSL88
Critser G.
Truth: a Bitter Pill for Drug Makers
The LA Times 2004 Jan 25
http://articles.latimes.com/2004/jan/25/opinion/op-critser25
HSL89
Barnett A .
Revealed: how stars were hijacked to boost health company's profits
The Observer 2004 Jan 25
http://www.guardian.co.uk/uk/2004/jan/25/society.research
HSL86
Harris , G AND, M .
F.D.A. Begins Push to End Drug Imports
New York Times 2004 Jan 24
http://www.nytimes.com/2004/01/24/business/24mail.html?pagewanted=1
HSL87
Walsh , B .
Tauzin turns down Hollywood but weighs new offer: Drug industry may be wooing 13-term congressman
The Times 2004 Jan 24
HSL83
Studwell , J .
Oh, behave!
Financial Times 2004 Jan 23
HSL84
Shapiro D.
Drug Companies Get Too Close for Med School's Comfort
The New York Times 2004 Jan 20
http://query.nytimes.com/gst/fullpage.html?sec=health&res=9F00E2D81439F933A15752C0A9629C8B63
HSL9787
Jacka M.
Mercenary hypocrisy at CMAJ.
CMAJ 2004 Jan 20; 170:(2):174
http://www.cmaj.ca/cgi/content/full/170/2/174-a
HSL2391
Jorgensen KJ, Gotzsche PC.
Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study.
BMJ 2004 Jan 17; 328:(7432):148
http://bmj.bmjjournals.com/cgi/content/full/328/7432/148
HSL193
Lee TH.
"Me-Too" Products — Friend or Foe?
N Engl J Med 2004 Jan 15; 350:(3):211-2
http://content.nejm.org/cgi/content/full/350/3/211
HSL3706
Burton B.
New Zealand moves to ban direct advertising of drugs.
BMJ 2004 Jan 10; 328:(7431):68
http://bmj.bmjjournals.com/cgi/content/full/328/7431/68-c
HSL9876
Hern JC.
Prescribing and dispensing of veterinary medicines.
Vet Rec 2004 Jan 10; 154:(2):60
HSL85
Pignarre P.
Health insurance: the bitter American lesson,
LE MONDE 2004 Jan 8
HSL2338
Stafford RS, Furberg CD, Finkelstein SN, Cockburn IM, Alehegn T, Ma J.
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.
JAMA 2004 Jan 7; 291:(1):54-62
http://jama.ama-assn.org/cgi/content/full/291/1/54
HSL9884
DeMaria AN.
Drug reimportation: sitting in the middle.
J Am Coll Cardiol 2004 Jan 7; 43:(1):149-50
http://linkinghub.elsevier.com/retrieve/pii/S0735109703014219
HSL9885
Austin PC, Mamdani MM, Tu K, Zwarenstein M.
Changes in prescribing patterns following publication of the ALLHAT trial.
JAMA 2004 Jan 7; 291:(1):44-5
http://jama.ama-assn.org/cgi/content/full/291/1/44
HSL1002
Gormley M.
Pfizer Settles Over Kids' Antibiotic Ads
Associated Press 2004 Jan 6
HSL1147
Woloshin S, Schwartz LM, Welch HG.
The value of benefit data in direct-to-consumer drug ads.
Health Aff (Millwood) 2004 Jan-Jun; Suppl Web Exclusives:W4-234-45
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.234v1
HSL1691
Cialdini RB, Goldstein NJ.
Social influence: compliance and conformity.
Annu Rev Psychol 2004; 55:591-621
http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.psych.55.090902.142015?cookieSet=1
HSL5316
Bell DS, Cretin S, Marken RS, Landman AB.
A conceptual framework for evaluating outpatient electronic prescribing systems based on their functional capabilities.
J Am Med Inform Assoc 2004 Jan-Feb 01; 11:(1):60-70
http://www.jamia.org/cgi/content/full/11/1/60
HSL194
Murray E, Lo B, Pollack L, Donelan K, Lee K.
Direct-to-consumer advertising: public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship.
J Am Board Fam Pract 2004 Jan; 17:(1):6-18
http://www.jabfp.org/cgi/content/full/17/1/6
HSL356
Svensson S, Mansfield PR.
Escitalopram: superior to citalopram or a chiral chimera?
Psychother Psychosom 2004 Jan-Feb; 73:(1):10-6
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=PPS2004073001010
HSL1138
Zoorob R, Larzelere M.
Gifts to physicians from the pharmaceutical and medical manufacturing industry: what every physician should know.
J La State Med Soc 2004 Jan-Feb; 156:(1):28-32
HSL1150
Weissman JS, Blumenthal D, Silk AJ, Newman M, Zapert K, Leitman R, Feibelmann S.
Physicians report on patient encounters involving direct-to-consumer advertising.
Health Aff (Millwood) 2004 Jan-Jun; Supplment Web Exclus:W4-219-33
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.219v1
HSL1155
Waxman HA.
Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?
Health Aff (Millwood) 2004 Jan-Jun; Supplment Web Exclus:W4-256-8
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.256v1
HSL1167
Sumpradit N, Ascione FJ, Bagozzi RP.
A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising.
Clin Ther 2004 Jan; 26:(1):135-54
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-4BSW890-G&_coverDate=01%2F31%2F2004&_alid=272329699&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6242&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=350cd528415b79ed8f6c00a62cff3cde
HSL1783
Bokhari SA.
How to become a biomedical (dental) journalist.
Saudi Med J 2004 Jan; 25:
HSL1787
Bennett WM.
Ethical conflicts for physicians treating ESRD patients.
Semin Dial 2004 Jan-Feb; 17:(1):1-3
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-139X.2004.17102.x?cookieSet=1
HSL1835
Keim S, Perina DG; CORD Board of Directors.
Council of Emergency Medicine Residency Directors position on interactions between emergency medicine residencies and the pharmaceutical industry.
Acad Emerg Med 2004 Jan; 11:(1):78
http://www.aemj.org/cgi/content/full/11/1/78
HSL1836
Keim SM, Mays MZ, Grant D.
Interactions between emergency medicine programs and the pharmaceutical industry.
Acad Emerg Med 2004 Jan; 11:(1):19-26
http://www.aemj.org/cgi/content/full/11/1/19
HSL2318
Hemminki E, Karttunen T, Hovi SL, Karro H.
The drug industry and medical practice--the case of menopausal hormone therapy in Estonia.
Soc Sci Med 2004 Jan; 58:(1):89-97
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-48TM3V5-2&_coverDate=01%2F31%2F2004&_alid=307376484&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=be686b45176e3a6cf270c9e1dedc43b1
HSL2385
Friedman LS, Richter ED.
Relationship between conflicts of interest and research results.
J Gen Intern Med 2004 Jan; 19:(1):51-6
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2004.30617.x?cookieSet=1
HSL2386
Reinhardt UE.
Perspective: An information infrastructure for the pharmaceutical market.
Health Aff (Millwood) 2004 Jan-Feb; 23:(1):107-12
http://content.healthaffairs.org/cgi/content/full/23/1/107
HSL2387
Jeffords JM.
Direct-to-consumer drug advertising: you get what you pay for.
Health Aff (Millwood) 2004 Jan-Jun; Suppl:
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.253v1
HSL2388
Kelly P.
DTC advertising's benefits far outweigh its imperfections.
Health Aff (Millwood) 2004 Jan-Jun; Suppl:
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.246v1
HSL2389
Pitts , P. J.
Turning point or tipping point: new FDA draft guidances and the future of DTC advertising
Health Aff 2004 Jan; Suppl Web Exclusives:W4-259-61
HSL2390
Riggs DL, Holdsworth SM, McAvoy DR.
Direct-to-consumer advertising: developing evidence-based policy to improve retention and comprehension.
Health Aff (Millwood) 2004 Jan-Jun; Suppl:
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.249v1
HSL4712
Malavige GN.
Doctors, drug companies and medical ethics: a Sri Lankan perspective.
Indian J Med Ethics 2004 Jan-Mar; 1:(1):26
HSL4713
Guha A.
A comparison of codes of pharmaceutical marketing practices.
Indian J Med Ethics 2004 Jan-Mar; 1:(1):19-21
HSL4714
Dabade G.
Unhealthy drug donations.
Indian J Med Ethics 2004 Jan-Mar; 1:(1):18
HSL4715
Bal A.
Can the medical profession and the pharmaceutical industry work ethically for better health care?
Indian J Med Ethics 2004 Jan-Mar; 1:(1):17
HSL4716
Gulhati CM.
Needed: closer scrutiny of clinical trials.
Indian J Med Ethics 2004 Jan-Mar; 1:(1):4-5
HSL4717
Roy N.
Who rules the great Indian drug bazaar?
Indian J Med Ethics 2004 Jan-Mar; 1:(1):2-3
HSL7339
Winckler SC.
Drug importation: What's legal, what's safe? - APhA lays out the facts for pharmacists and their patients
Journal of the Pharmacy Society of Wisconsin 2004 Jan-Feb; 16-18
HSL7349
Berndt ER.
Perspective: Unique issues raised by drug benefit design.
Health Aff (Millwood) 2004 Jan-Feb; 23:(1):103-6
http://content.healthaffairs.org/cgi/content/full/23/1/103
HSL7350
Newhouse JP.
How much should Medicare pay for drugs?
Health Aff (Millwood) 2004 Jan-Feb; 23:(1):89-102
http://content.healthaffairs.org/cgi/content/full/23/1/89
HSL7351
Pammolli F, Riccaboni M.
Perspective: Market structure and drug innovation.
Health Aff (Millwood) 2004 Jan-Feb; 23:(1):48-50
http://content.healthaffairs.org/cgi/content/full/23/1/48
HSL9735
Ghosh A, Hazra A, Mandal SC.
New drugs in India over the past 15 years: analysis of trends.
Natl Med J India 2004 Jan-Feb; 17:(1):10-6
HSL9766
Haynes SV, Dudderidge TJ.
Emergency contraception: the journey so far.
BJOG 2004 Jan; 111:(1):91
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1471-0528.2003.00020.x
HSL9777
Sellar PW.
Re: confusion between similarly named eye drops.
Eye 2004 Jan; 18:(1):111-2
http://www.nature.com/eye/journal/v18/n1/abs/6700570a.html;jsessionid=2F2DD8EC85EB55D8E0DCACA754334075
HSL9783
Mansour D, Trueman G.
Off-licence prescribing in contraception.
J Fam Plann Reprod Health Care 2004 Jan; 30:(1):9-10
http://www.popline.org/ics-wpd/exec/icswppro.dll?BU=http%3A%2F%2Fwww.popline.org%2Fics-wpd%2Fexec%2Ficswppro.dll&QF0=DocNo&QI0=186506&TN=Popline&AC=QBE_QUERY&MR=30&DL=1&&RL=1&&RF=LongRecordDisplay&DF=LongRecordDisplay
HSL9790
Evans L.
Prices, patents and productivity
Current Drug Discovery 2004 Jan; 33-35
HSL9989
Business Insights
Harnessing Patient Power: Strategies for speeding drug approval, building and retaining market share
: Business Insights 2004 Jan
http://www.piribo.com/publications/regulation_policy/harnessing_patient_power.html
HSL11461
Etemadi A, Raiszadeh F, Alaeddini F, Azizi F.
Views of Iranian medical journal editors on medical research publication.
Saudi Med J 2004 Jan; 25:(1):
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=14968189
HSL13325
Wright RF, Lundstrom WJ.
Physicians' perceptions of pharmaceutical sales representatives: A model for analysing the customer relationship
International Journal of Medical Marketing 2004 Jan; 4:(1):29-38
http://www.ingentaconnect.com/content/pal/jmm/2004/00000004/00000001/art00005
Page 7 of 9 pages ‹ First < 5 6 7 8 9 >
